CCNA2 and glioblastoma: As expected, inhibition of CDK2 with Milciclib alone or in combination with JQ1 selectively reduced Cyclin A levels in GTML2 compared to control (Fig. 2c), in line with results from Milciclib treatment in GBM cells [31].